IP Library Granted Patent US 11,583,243
Granted Patent B2
US 11,583,243 · App. 17/232,051 · Granted Feb 21, 2023

Methods and systems for controlled deployment of needle structures in tissue

Inventors: Michael A. Munrow (Belmont, CA); Darrin Uecker (San Mateo, CA); Brian Placek (Menlo Park, CA); Harry Kwan (San Francisco, CA); David Toub (Wyncote, PA); Cameron D. Hinman (Thurmond, NC); David J. Danitz (San Jose, CA)
Assignee: Gynesonics, Inc.
A61B8/0841A61B5/066A61B8/12A61B8/445A61B8/463A61B18/1477A61B34/25A61B8/145A61B8/461A61B8/467A61B18/02A61B18/042A61B18/1485A61B18/1815A61B90/04A61B2018/00559A61B2018/00577A61B2018/00702A61B2018/00761A61B2018/00898A61B2018/00904A61B2018/00982A61B2018/0293A61B2018/143A61B2018/1475A61B2034/104A61B2034/107A61B2034/2063A61B2034/254A61B2090/034A61B2090/0427A61B2090/378A61B2090/3782A61B2090/3784A61N2007/025F04C2270/041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,583,243
App. No.
17/232,051
Granted
Feb 21, 2023
Kind
B2
Abstract

A system for deploying needles in tissue includes a controller and a visual display. A treatment probe has both a needle and tines deployable from the needle which may be advanced into the tissue. The treatment probe also has adjustable stops which control the deployed positions of both the needle and the tines. The adjustable stops are coupled to the controller so that the virtual treatment and safety boundaries resulting from the treatment can be presented on the visual display prior to actual deployment of the system.

Claims (37)

1. A method for deploying a needle structure of a tissue treatment system, the method comprising:

positioning a probe comprising the needle structure near a uterine fibroid to be ablated, the needle structure comprising a needle and a plurality of tines extendable from the needle, and the probe further comprising a handle and a deployment mechanism for the needle structure within the handle;

using an ultrasound imaging transducer of the tissue treatment system, providing a real time image of the uterine fibroid on a display;

using the tissue treatment system, displaying a treatment region on the real time image, wherein a size of the treatment region displayed on the real-time image is determined at least partially based on an actual or a planned extent of advancement of the plurality of tines from the needle and on a planned duration of application of radiofrequency energy applied to the needle structure, wherein the actual or planned extent of advancement of the plurality of tines is tracked by one or more sensors operatively coupled to the deployment mechanism within the handle of the probe;

inserting the needle structure into the uterine fibroid; and

using the probe, ablating the uterine fibroid based on the displayed treatment region, including applying radiofrequency energy to the needle structure.

2. The method of claim 1 , further comprising extending the plurality of tines from the needle.

3. The method of claim 2 , wherein extending the plurality of tines from the needle comprises distally advancing a slider of a handle of the probe.

4. The method of claim 2 , further comprising tracking the extending of the tines.

5. The method of claim 1 , wherein the ultrasound imaging transducer is introduced laparoscopically.

6. The method of claim 1 , wherein the ultrasound imaging transducer is introduced transvaginally.

7. The method of claim 1 , wherein positioning the probe comprises laparoscopically positioning the probe.

8. The method of claim 1 , wherein positioning the probe comprises transvaginally positioning the probe.

9. A method for deploying a needle structure of a tissue treatment system, the method comprising:

positioning a probe comprising the needle structure near an anatomical feature, the needle structure comprising a needle and a plurality of tines extendable from the needle, and the probe further comprising a deployment mechanism for the needle structure;

using an image source, providing a real time image of the anatomical feature on a display; and

using the tissue treatment system, displaying a treatment region on the real time image, wherein a size of the treatment region displayed on the real-time image is determined at least partially based on an actual or a planned extent of advancement of the plurality of tines from the needle and on a duration of application of energy applied to the needle structure, wherein the actual or planned extent of advancement of the plurality of tines is tracked by one or more sensors operatively coupled to the deployment mechanism of the probe.

10. The method of claim 9 , further comprising:

inserting the needle structure into the anatomical feature; and

extending the plurality of tines from the needle.

11. The method of claim 10 , wherein extending the plurality of tines comprises distally advancing a slider of a handle of the probe.

12. The method of claim 10 , further comprising tracking the extending of the plurality of tines.

13. The method of claim 9 , further comprising using the probe, ablating the anatomical feature based on the displayed treatment region, including applying radiofrequency energy to the needle structure, wherein the size of the treatment region is varied at least partially based on the duration of application of the radiofrequency energy.

14. The method of claim 9 , wherein the anatomical structure comprises a uterine fibroid.

15. The method of claim 9 , wherein providing the real time image comprises an ultrasound image.

16. The method of claim 15 , wherein the probe comprises an ultrasound imaging transducer.

17. The method of claim 15 , wherein a second probe separate from the probe comprises an ultrasound imaging transducer.

18. The method of claim 9 , wherein positioning the probe comprises introducing the probe laparoscopically.

19. The method of claim 9 , wherein positioning the probe comprises introducing the probe transvaginally.

20. The method of claim 2 , wherein extending the plurality of tines from the needle is after inserting the needle structure into the uterine fibroid.

21. The method of claim 1 , wherein the size of the treatment region is determined at least partially based on the planned extent of advancement of the plurality of tines from the needle and on the planned duration of application of radiofrequency energy applied to the needle structure, wherein inserting the needle structure into the uterine fibroid is after displaying the treatment region on the real time image.

22. The method of claim 1 , wherein the tissue treatment system comprises a system controller, the display, and the probe comprising the needle structure, wherein the probe further comprises the ultrasound imaging transducer, and wherein the system controller is operatively coupled to the display and the probe.

23. The method of claim 9 , wherein the image source is an ultrasound imaging transducer.

24. The method of claim 10 , wherein extending the plurality of tines from the needle structure is after inserting the needle structure into the anatomical feature.

25. The method of claim 10 , wherein the size of the treatment region is determined at least partially based on the planned extent of advancement of the plurality of tines from the needle and on the planned duration of application of energy applied to the needle structure, wherein inserting the needle structure into the anatomical feature is after projecting the treatment region on the real time image.

26. The method of claim 9 , wherein the tissue treatment system comprises a system controller, the display, and the probe comprising the needle structure, and wherein the system controller is operatively coupled to the display and the probe.

27. The method of claim 26 , wherein the probe further comprises the image source.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: MUNROW, MICHAEL A.; UECKER, DARRIN; PLACEK, BRIAN; KWAN, HARRY; TOUB, DAVID; HINMAN, CAMERON D.; DANITZ, DAVID J.
To: GYNESONICS, INC.
Reel/Frame 055936/0900 →
Continuity (5)
Continuation 17084141 · Oct 29, 2020
Continuation 15793874 · Oct 25, 2017
Continuation 13801782 · Mar 13, 2013
Provisional Application 61698196 · Sep 7, 2012
Related Publication 20210228179A1 · Jul 29, 2021
Cited By (2)
US 12,239,382 US 12,383,224